Fitzgerald Kevin Joseph
SEC insider (Form 3/4/5 filer). CIK 0001886431. Director at Ovid Therapeutics Inc. (OVID) and 1 other issuer. 150 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in NEW YORK, NY.
Companies Fitzgerald Kevin Joseph has filed insider reports for
- Ovid Therapeutics Inc. (OVID): Director
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Officer, CSO & EVP, Head of Research
Fitzgerald Kevin Joseph
CIK: 0001886431
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (150 total)
- Apr 7, 2026OVID
Ovid Therapeutics Inc.
AwardDirect17.6K shares at avg. $2.56$45K - Mar 5, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect233 shares at avg. $323.25$75K - Mar 5, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect124 shares at avg. $321.81$40K - Mar 5, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect153 shares at avg. $326.24$50K - Mar 5, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect148 shares at avg. $324.60$48K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect79 shares at avg. $321.82$25K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect59 shares at avg. $320.81$19K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect96 shares at avg. $323.01$31K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect29 shares at avg. $319.03$9K - Mar 4, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
SaleDirect57 shares at avg. $325.67$19K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 7, 2026 |  OVID Ovid Therapeutics Inc. | Award | 17,578 | $2.56 | $45,000 | Direct |
| Mar 5, 2026 |  ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 233 | $323.25 | $75,317 | Direct |
| Mar 5, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 124 | $321.81 | $39,904 | Direct |
| Mar 5, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 153 | $326.24 | $49,915 | Direct |
| Mar 5, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 148 | $324.60 | $48,041 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 79 | $321.82 | $25,424 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 59 | $320.81 | $18,928 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 96 | $323.01 | $31,009 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 29 | $319.03 | $9,252 | Direct |
| Mar 4, 2026 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Sale | 57 | $325.67 | $18,563 | Direct |
1-10 of 150 transactions